Mark D. Stegall, M.D.
Mayo Clinic
6
6
5
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (6)
Research Network
Collaboration Network
Research Areas & Affiliations
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Arthur Matas, MD
University of Minnesota
Shared therapeutic areas:
Worked with same sponsors:
Jeffrey B Kopp, M.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Shared therapeutic areas:
Raymond Vanholder, MD, PhD
University Hospital, Ghent
Shared therapeutic areas:
Worked with same sponsors:
Yu-Chang Yeh, PhD
National Taiwan University Hospital
Shared therapeutic areas:
John Flaherty, PharmD
Gilead Sciences
Shared therapeutic areas:
E. Steve Woodle, MD
University of Cincinnati
Shared therapeutic areas:
Worked with same sponsors:
Paul Perez, Dr
University Hospital, Bordeaux
Shared therapeutic areas:
Jin li Zhang, MD
Department of nephrology, People's Hospital of Yunnan Province
Shared therapeutic areas:
Sung-Han Kim, MD
Asan Medical Center
Shared therapeutic areas:
Julien Aniort
University Hospital, Clermont-Ferrand
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (6)
Showing 6 of 6 trials
Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Cross Match Living Donor Kidney Transplant
A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin Inhibitors
The Comparison of Three Different Immunosuppressant Regimens in Kidney Transplant Recipients.
The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients
A Study That Will Look at the Impact of Immunosuppression on Antibody Production in Kidney Transplant Recipients.
The Impact of Velcade(TM)on Antibody Secreting Cells in Sensitized Renal Allograft Candidates
All 6 trials loaded